Voluntary Antibiotic Recall Initiated

Article

Three lots of ertapenem, (Invanz) 1g (0803930, 0803940, and 0803950), a Merck antibiotic that is indicated for the treatment of patients with moderate to severe infections, were recalled because of two incidents of broken glass found in the reconstituted solution for injection [more].

Three lots of ertapenem, (Invanz) 1g (0803930, 0803940, and 0803950), a Merck antibiotic that is indicated for the treatment of patients with moderate to severe infections, were recalled because of two incidents of broken glass found in the reconstituted solution for injection. Healthcare professionals are advised to immediately stop dispensing all products from the three lots specified above. All lots have an expiration date of October 2008, and no other lots were affected by this recall. Medical questions about the recall can be directed to Merck’s national service center at 800–672–6372.

Recent Videos
cUTI Roundtable: Discussing and diagnosing these difficult infections
Willough Jenkins, MD
Discussing health care sustainability, climate change, and WHO's One Health goal | Image credit: Provided by Shreya Doshi
Willough Jenkins, MD
Screening for and treating the metatarsus adductus foot deformity |  Image Credit: UNFO md ltd
Wendy Ripple, MD
Wendy Ripple, MD
Courtney Nelson, MD
DB-OTO improved hearing to normal in child with profound genetic deafness | Image Credit: © Marija - © Marija - stock.adobe.com.
© 2024 MJH Life Sciences

All rights reserved.